Yifan Pharmaceutical: Injection Concentrate of Metaraminol Bitartrate receives approval for registration in Singapore.

On February 6, Yi Fan Pharmaceuticals announced that its wholly-owned subsidiary, SciGen Pte. Ltd., recently received approval from the Health Sciences Authority of Singapore to issue a registration certificate for the listing, allowing the company's pharmaceutical product Epinephrine Hydrogen Tartrate Concentrate for Injection to be sold in Singapore. This drug is used for blood pressure control in adults with severe, acute hypotensive states.